Literature DB >> 7339788

Evaluation of antibiotic usage: a comprehensive look at alternative approaches.

C M Kunin.   

Abstract

Current problems related to the use of antibiotics in the United States are summarized. In 1979, pharmaceutical manufacturers shipped +1.55 billion worth of anti-infective drugs. It is estimated that in approximately one-half of all cases that involve administration of antibiotics in the hospital, either the medical condition does not require antibiotic treatment, the most effective and least expensive drug is not chosen, or the correct dosage or duration of therapy is not prescribed. Much of the high cost of antibiotic therapy can be attributed to the use of expensive antibiotics of the cephalosporin and aminoglycoside groups and to the excessive duration of antibiotic prophylaxis in surgery. This review presents methods that assess the magnitude of the problem by audit and analyzes the corrective approaches that have been suggested. The major issues of concern related to the use of antibiotics are the complex series of considerations that lead physicians to prescribe antibiotics and the problem of patient expectation and compliance. Excessive usage of antibiotics must be viewed as part of the problem of overusage of all drugs and laboratory procedures.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7339788     DOI: 10.1093/clinids/3.4.745

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  11 in total

1.  A multidisciplinary hospital-based antimicrobial use program: Impact on hospital pharmacy expenditures and drug use.

Authors:  S Salama; C Rotstein; L Mandell
Journal:  Can J Infect Dis       Date:  1996-03

2.  Quality of use of parenteral metronidazole therapy in a teaching hospital.

Authors:  P J Jewesson; R L Bachand; G A Bell; R J Ensom; A W Chow
Journal:  Can Med Assoc J       Date:  1985-04-01       Impact factor: 8.262

3.  Implementation and evaluation of a preprinted perioperative antimicrobial prophylaxis order form in a teaching hospital.

Authors:  P Au; S Salama; C Rotstein
Journal:  Can J Infect Dis       Date:  1998-05

Review 4.  Cephalosporin utilisation review and evaluation.

Authors:  G M Misan; C Dollman; D R Shaw; N Burgess
Journal:  Pharmacoeconomics       Date:  1995-08       Impact factor: 4.981

Review 5.  An overview of nosocomial infections, including the role of the microbiology laboratory.

Authors:  T G Emori; R P Gaynes
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

6.  Dealing with the misuse of antibiotics in the hospital.

Authors:  P J Jewesson; A W Chow
Journal:  Can Med Assoc J       Date:  1983-05-01       Impact factor: 8.262

7.  The use of new broad spectrum antibiotics.

Authors:  F Follath
Journal:  Intensive Care Med       Date:  1985       Impact factor: 17.440

8.  Clinical consequences of development of resistance to third generation cephalosporins.

Authors:  F Follath; E Costa; A Thommen; R Frei; A Burdeska; J Meyer
Journal:  Eur J Clin Microbiol       Date:  1987-08       Impact factor: 3.267

9.  Prescription of antibiotics to out-patients in hospital clinics, community health centres and private practice.

Authors:  S Mölstad; B Hovelius; L Kroon; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

10.  Auditing antibiotic use in a teaching hospital: focus on cefoxitin.

Authors:  P J Jewesson; R Ho; Q Jang; G Watts; A W Chow
Journal:  Can Med Assoc J       Date:  1983-05-01       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.